Allergies News and Research

Latest Allergies News and Research

Most kids recover from Lyme disease within six months of completing antibiotic treatment

A majority of parents of children diagnosed with Lyme disease reported that their kids recovered within six months of completing antibiotic treatment, according to a new joint study from Children's National Research Institute and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, published in Pediatric Research.

21 Apr 2023

Greenness around the home does not protect children from atopic eczema

According to a new Finnish study, greenness around the home in early childhood does not seem to protect children from atopic eczema.

21 Apr 2023

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial conducted in the first half of 2021 and co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

20 Apr 2023

GW one of 18 clinical trial sites across the United States testing monkeypox vaccine in adolescents

The National Institutes of Health trial to evaluate the mpox (previously known as monkeypox) vaccine JYNNEOS has now entered the next stage and is studying the immune responses to and the safety of the vaccine in adolescents.

19 Apr 2023

The importance and challenges of developing mucosal SARS-COV-2 vaccines

In November 2022, the National Institute of Allergy and Infectious Diseases co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2.

13 Apr 2023

The confusing fate of the abortion pill

The abortion pill mifepristone is now ground zero in the abortion debate.

13 Apr 2023

How to combat and lessen seasonal allergy symptoms

Welcoming spring this year has been bittersweet for the millions of allergy sufferers already experiencing itchy eyes, nasal congestion, sneezing and runny noses.

13 Apr 2023

Cornell receives $9.5 million NIH grant for chronic fatigue research

A Cornell multidisciplinary research center that studies chronic fatigue syndrome has received a five-year, $9.5 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Disease – funding that will enable experts from disparate fields to work together on the mysterious and debilitating condition.

11 Apr 2023

Daily statin medication could improve cardiovascular outcomes in people with HIV

A National Institutes of Health clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

11 Apr 2023

Mint flavor in vaping liquids associated with worse lung function in e-cigarette users

Adding mint flavor to e-cigarette liquids produces more vapor particles and is associated with worse lung function in those who smoke, report researchers from the University of Pittsburgh in Respiratory Research today.

11 Apr 2023

Regulatory T cell populations descend from two different origins, finds study

A regulatory class of human T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity, according to a new study led by Children's Hospital of Philadelphia (CHOP).

7 Apr 2023

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having condomless sex, according to findings published today in the New England Journal of Medicine.

6 Apr 2023

Children with asthma more likely to develop anxiety

Children diagnosed with asthma were at significantly increased risk of developing anxiety, a University of Queensland study has found.

5 Apr 2023

Mosquitoes' saliva contains immune-dampening substances to increase infectivity of dengue viruses

The saliva of mosquitoes infected with dengue viruses contains a substance that thwarts the human immune system and makes it easier for people to become infected with these potentially deadly viruses, new research reveals.

4 Apr 2023

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.

4 Apr 2023

UCSD engineers develop a biodegradable polymer system to treat rheumatoid arthritis

A team led by engineers at the University of California San Diego has developed a biodegradable polymer system to treat rheumatoid arthritis, an autoimmune and inflammatory disease, by working in concert with the power of the human immune system.

4 Apr 2023

N-abling the acceleration of the life sciences through precision dispensing

In this interview, we speak to Holger Eickhoff, CEO and Founder of Scienion, about their latest technology, The Nucleus Automation Ecosystem.

From SCIENION GmbH 4 Apr 2023

Developing lipid nanoparticles to carry mRNA specifically to the pancreas

Therapeutics that use mRNA - like some of the COVID-19 vaccines - have enormous potential for the prevention and treatment of many diseases.

31 Mar 2023

What is the effect of supplementing raisins on improving cognitive performance, cardiovascular risk factors, and markers of inflammation?

Researchers devised a protocol to examine the effect of raisin supplementation on cognitive function in older adults.

31 Mar 2023

AI tool helps clinicians to identify and treat lung cancer at their early stages

A new artificial intelligence (AI) tool is helping physicians at Atrium Health Wake Forest Baptist better predict and diagnose lung cancer in patients.

29 Mar 2023

Allergies News and Research

Latest Allergies News and Research

Most kids recover from Lyme disease within six months of completing antibiotic treatment

Greenness around the home does not protect children from atopic eczema

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

GW one of 18 clinical trial sites across the United States testing monkeypox vaccine in adolescents

The importance and challenges of developing mucosal SARS-COV-2 vaccines

The confusing fate of the abortion pill

How to combat and lessen seasonal allergy symptoms

Cornell receives $9.5 million NIH grant for chronic fatigue research

Daily statin medication could improve cardiovascular outcomes in people with HIV

Mint flavor in vaping liquids associated with worse lung function in e-cigarette users

Regulatory T cell populations descend from two different origins, finds study

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

Children with asthma more likely to develop anxiety

Mosquitoes' saliva contains immune-dampening substances to increase infectivity of dengue viruses

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

UCSD engineers develop a biodegradable polymer system to treat rheumatoid arthritis

N-abling the acceleration of the life sciences through precision dispensing

Developing lipid nanoparticles to carry mRNA specifically to the pancreas

What is the effect of supplementing raisins on improving cognitive performance, cardiovascular risk factors, and markers of inflammation?

AI tool helps clinicians to identify and treat lung cancer at their early stages

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Allergies News and Research

Latest Allergies News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in